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OBJECTIVES The purpose of the study was to investigate whether cholesterol metabolism is associated with
coronary artery disease (CAD) in postmenopausal women.
BACKGROUND Although hypercholesterolemia, a predominant risk factor of CAD, is related to cholesterol
metabolism, the association between cholesterol metabolism and CAD is not well known.
METHODS In addition to conventional coronary risk factors, fasting serum squalene, D8-cholestenol,
desmosterol, lathosterol (indicators of cholesterol synthesis), cholestanol, campesterol and
sitosterol (indicators of cholesterol absorption) were measured in 48 50- to 55-year-old
consecutive women with angiographically verified CAD and in 61 age-matched healthy
controls.
RESULTS The coronary patients had elevated ratios of squalene (p , 0.001), desmosterol (p 5 0.005),
campesterol (p 5 0.028) and sitosterol (p 5 0.022) to cholesterol, but had lower respective
lathosterol value (p 5 0.041) compared with the controls, despite similar serum cholesterol
levels. Adjusted for age, body mass index, family history of CAD, smoking, hypertension,
serum triglycerides, low-density lipoprotein (LDL) and high-density lipoprotein (HDL)
cholesterol level and glycosylated hemoglobin A1c% (GHbA1c), the ratios of squalene (odds
ratio, 1.36; 95% confidence interval, 1.17 to 1.57), lathosterol (0.98; 0.97 to 0.99),
campesterol (1.01; 1.00 to 1.01) and sitosterol (1.01; 1.00 to 1.03) were significantly
associated with the risk of CAD. In addition, family history of CAD and GHbA1c% were
also independently related to the presence of CAD.
CONCLUSIONS The results suggest that women with elevated ratios of serum squalene, campesterol and
sitosterol to cholesterol and low respective lathosterol values have enhanced risk for CAD.
Thus, enhanced absorption and reduced synthesis of cholesterol may be related to coronary
atherosclerosis. (J Am Coll Cardiol 2000;35:1185–91) © 2000 by the American College of
Cardiology
During the past few decades, serum total cholesterol has
been established as a strong independent risk factor for
atherosclerosis (1). Consequently, effective lowering of se-
rum cholesterol level results in a marked reduction of
different clinical manifestations of coronary heart disease
both in primary and secondary prevention (2,3). Serum
cholesterol concentration is also regulated by cholesterol
metabolism (i.e., synthesis, absorption and elimination)
(4,5), which in turn are influenced by dietary fat and
cholesterol intake (6). Cholesterol synthesis rate and ab-
sorption efficiency can be reflected by measuring serum
noncholesterol sterols with gas–liquid chromatography
(GLC) (7–11). Serum cholesterol precursors, including
squalene, lanosterol and other methylated sterols, desmos-
terol and lathosterols, are positively related to cholesterol
synthesis rate (7,8), even though the association with
squalene is controversial (9–12).
Plant sterols, solely of dietary origin, such as campesterol
and sitosterol, and cholestanol, a metabolite of cholesterol,
are related to cholesterol absorption efficiency (10,11). Even
though hypercholesterolemia has been well defined as a
major risk factor in coronary patients, association of choles-
terol metabolism and serum noncholesterol sterols with
coronary artery disease (CAD) and its lipid and nonlipid
risk factors is not clear. In recent studies, reduction of
coronary events by simvastatin treatment was positively
associated with basal ratios of cholestanol and plant sterols
to cholesterol (13). In addition to cholesteryl esters,
squalene has also been found in human atherosclerotic
plaques (14), but its significance as a risk factor for CAD has
not been studied. Accordingly, in addition to conventional
From the Division of Internal Medicine, Department of Medicine, University of
Helsinki, Helsinki, Finland. The study was supported by grants from the Clinical
Research Institute of the Helsinki University Central Hospital; the Research
Foundation of Orion Corporation; the Finnish Academy of Medical Sciences;
Helsinki University Central Hospital, and Finnish Heart Research Foundation.
Manuscript received July 1, 1999; revised manuscript received October 27, 1999,
accepted December 15, 1999.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000
© 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00
Published by Elsevier Science Inc. PII S0735-1097(00)00527-1
risk factors of CAD, squalene and noncholesterol sterols in
fasting sera were assessed in postmenopausal women with
angiographically documented CAD and were compared to
postmenopausal controls.
METHODS
Subjects. The study recruited 50–55-year-old consecutive
postmenopausal coronary patients who had been succes-
sively treated for CAD in the University Central Hospital of
Helsinki between 1988 and 1996. Twenty-nine coronary
women had suffered from myocardial infarction, 26 had
been treated with angioplasty and 21 with bypass surgery, all
at least six months earlier. Coronary angiography was
interpreted to be pathological with at least 50% occlusion in
two coronary vessels. Age-matched postmenopausal women
were randomly chosen from the population registry of
Helsinki as controls. The controls were free of chest pain
and dyspnea, and their electrocardiograms (ECGs) were
normal. Postmenopause was defined by amenorrhea and
elevated serum follicle-stimulating hormone level (FSH .
30 U/liter). Hypolipidemic drug users and subjects with
severe heart, liver or digestive tract or malignant diseases
were excluded.
All subjects underwent physical examinations before col-
lection of blood samples following a 12-h fast. History of
CAD in family members, and smoking history and medi-
cations, including hormone replacement therapy, were re-
corded and blood pressure was measured. Beta-blocker
medication was more common among the cases than among
healthy control women (Table 1). Calcium blockers were
Abbreviations and Acronyms
BMDP 5 Biomedical Data Program
CAD 5 coronary artery disease
ECG 5 electrocardiogram
FSH 5 follicle-stimulating hormone
GHbA1c 5 glycosylated hemoglobin A1c
GLC 5 gas–liquid chromatography
HDL 5 high-density lipoprotein
LDL 5 low-density lipoprotein
Q 5 quartiles
ROC 5 receiver operating characteristic
SHBG 5 sex hormone binding globulin
Table 1. Baseline Characteristics
Characteristic
Cases
(n 5 48)
Controls
(n 5 61)
p
Value
Age (yrs) 53.1 6 0.5 53.6 6 0.4 . 0.1
Body mass index (kg/m2) 26.0 6 0.6 26.7 6 0.6 . 0.1
Apolipoprotein E2/E3/E4 (n) 1/25/22 2/34/25 . 0.1
Dietary fat intake (gzkg21zd21)* 1.10 6 0.08 1.11 6 0.07 . 0.1
Dietary cholesterol intake (mgzkg21zd21)* 4.09 6 0.37 4.13 6 0.25 . 0.1
Dietary plant sterol intake (mgzkg21zd21)* 4.15 6 0.23 4.64 6 0.23 0.092
Family history of CAD (n) 39 20 , 0.001
Hypertension (n) 22 15 0.020
Systolic blood pressure (mm Hg) 133.7 6 4.1 132.7 6 2.9 . 0.1
Diastolic blood pressure (mm Hg) 83.4 6 1.5 84.7 6 1.6 . 0.1
Beta-blocker users (n) 34 6 , 0.001
Exogenous hormone users (n) 18 28 . 0.1
Smokers (n) 26 18 0.013
Serum cholesterol (mmol/liter)
Total 5.94 6 0.14 5.71 6 0.12 . 0.1
Low density lipoprotein 3.99 6 0.12 3.66 6 0.12 0.024
High density lipoprotein 1.31 6 0.03 1.50 6 0.05 0.003
Serum triglycerides (mmol/liter) 1.39 6 0.09 1.21 6 0.09 0.055
Blood hemoglobin (g/liter) 143.8 6 1.4 138.2 6 1.2 0.002
Blood glucose (mmol/liter) 4.61 6 0.11 4.57 6 0.08 . 0.1
Blood GHb A1c (%) 5.61 6 0.06 5.30 6 0.05 , 0.001
Serum insulin (mU/liter) 8.47 6 0.60 8.71 6 0.81 . 0.1
Serum SHBG (nmol/liter) 68.9 6 5.2 67.4 6 4.8 . 0.1
Serum FSH (U/liter) 40.9 6 4.1 40.5 6 3.6 . 0.1
Serum thyrotropin (mU/liter) 2.87 6 0.32 2.87 6 0.35 . 0.1
Blood leukocyte (xE9/liter) 6.15 6 0.21 5.70 6 0.29 0.016
Erythrocyte sedimentation rate (mm/h) 13.5 6 1.7 10.9 6 1.0 . 0.1
CAD 5 coronary artery disease; GHbA1c 5 glycosylated hemoglobin A1c; FSH 5 follicle-stimulating hormone; SHBG 5 sex
hormone binding globulin; apolipoprotein E2 5 phenotype 2/3; apolipoprotein E3 5 phenotype 3/3; apolipoprotein E4 5
phenotypes 2/4, 3/4 and 4/4. Differences between continuous variables were analyzed by Mann-Whitney rank-sum test and
categorical values by chi-square test.
*Randomly measured in 29 cases and 41 controls.
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being taken by 16 of the cases and by 4 control women,
diuretics, respectively, by 3 and 5, whereas angiotensin-
converting enzyme inhibitors were used by 3 and 5, respec-
tively. Eighteen coronary patients and 28 healthy women
used exogenous hormone substitution. Nine women in the
case group and 10 in the control group used estrogens, and
2 women in each group used progestin only, whereas 7
coronary patients and 16 healthy women used both estrogen
and progestin. The study was approved by the ethics
committee of our hospital. All subjects volunteered for the
study and gave informed consent.
Baseline measurements. Subjects were advised to continue
their normal diets, and dietary fat and cholesterol were
calculated from seven-day dietary recalls (15). Cholesterol
and triglycerides were measured enzymatically by commer-
cial kits (Boehringer Diagnostica, Germany). Low-density
lipoprotein (LDL) cholesterol was calculated by Friedewald
formula (16) as triglyceride values were below 3 mmol/liter
in every subject. Cholesterol, squalene and noncholesterol
sterols were measured by GLC from the same run as
described earlier (12,17), so that the ratios to cholesterol
could be adequately calculated. Briefly, 5 a-cholestane was
added to serum samples as an internal standard after which
the samples were saponified with 95% ethanol and KOH.
Nonsaponified lipids were extracted by hexane, and
squalene and noncholesterol sterols were quantitated on a
50-m-long Hewlett-Packard Ultra I column, using com-
mercial squalene and noncholesterol sterols to localize their
peaks. An average of two baseline squalene and noncholes-
terol sterol concentrations were used in the following.
Serum squalene and noncholesterol sterol concentration
were both positively and significantly correlated with serum
total cholesterol concentration, as squalene and sterols are
carried in serum by lipoproteins, mainly by LDL. There-
fore, squalene and noncholesterol sterol values were ex-
pressed in ratio to cholesterol to eliminate the interindi-
vidual variation of the lipoprotein levels.
Blood hemoglobin was measured by electronic blood cell
counter; leukocytes were measured by microscopic evalua-
tion with May-Gru¨nwald-Giemsa stain; erythrocyte sedi-
mentation rate by Westergren method; serum thyrotropin
by immunoluminometric assay (18); serum FSH by immu-
noluminometric assay (19); serum sex hormone binding
globulin (SHBG) by immunofluorometric assay (20); serum
insulin by radioimmunoassay (21); blood glycosylated he-
moglobin A1c (GHbA1c) by high-performance liquid
chromatography (22); and blood glucose was measured
enzymatically (hexokinase).
Data analysis. Continuous variables were presented as
mean value 6 SE. Group differences were analyzed by the
Mann-Whitney rank-sum test. Relationships between con-
tinuous variables were assessed by the Spearman rank
correlation test and between categorical and continuous
variables by the chi-square test. For the latter test, contin-
uous variables were divided at the median point into two
categories. Associations between CAD and all other param-
eters were first analyzed by univariate logistic regression
analysis and then by multivariate analysis, based on maxi-
mum likelihood ratio. The presence of CAD was included
into the model as the dependent variable, and family history
of CAD (yes or no), smoking (yes or no) and hypertension
(yes or no) as independent categorical variables and others as
independent continuous variables. Goodness of fit to the
prediction was examined by Hosmer-Lemeshow and logis-
tic function by the C.C. Brown test.
To compare the probability of the correct risk evaluation
by squalene to cholesterol ratio, LDL cholesterol and serum
triglycerides, receiver operating characteristic (ROC) curves
were drawn by plotting the proportions of true positive
results (sensitivity) versus the proportions of false positive
results (1-specificity). Study subjects were rated on their risk
for CAD based on quartiles (Q) of the factors (i.e., gradually
increasing risk from Q1 to Q4). The ROC curves were
described by area under the curve. Statistical analysis was
performed with Biomedical Data Program (BMDP) statis-
tical software package. A p value less than 0.05 was
considered significant.
RESULTS
Baseline characteristics. The mean age, body mass index,
frequency of apolipoprotein E phenotypes and exogenous
hormone users and dietary intakes of fat, cholesterol and
plant sterols were similar among the women without and
with CAD (Table 1). Eighty-one percent of the coronary
patients and 33% of the healthy women had family history
of CAD. The ratio was 2.5 times larger in the case group
than in the control group (p , 0.000). The coronary
patients had significantly higher frequency of smokers and
hypertensive subjects, elevated concentrations of LDL cho-
lesterol, GHbA1c, hemoglobin and leukocytes and lower
levels of high density lipoprotein (HDL) cholesterol com-
pared with the healthy women controls. In concentration
and ratio to cholesterol, squalene, desmosterol, campesterol
and sitosterol were significantly higher and those of latho-
sterol were lower in the case group than in the control group
(Table 2). Among nonsmokers, non–beta-blocker users and
nonhormone users, the cases still had significantly higher
ratios of squalene and plant sterols and lower respective
lathosterol values than did the controls. The women with
and without exogenous hormones and beta- and calcium-
blocking agents had similar concentrations of baseline
parameters in both groups.
Relationship between the factors associated with CAD.
The ratios of squalene were positively associated with those
of desmosterol and GHbA1c%, and negatively with HDL
cholesterol level (Table 3). An inverse association between
serum total cholesterol concentrations and squalene ratios
was found in the coronary patients and less consistently in
the controls (Fig. 1), even though the squalene values below
the median showed a significant respective correlation (r 5
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20.30, p 5 0.033). The squalene content of serum choles-
terol was lower in the controls than in the cases, especially
in lower and higher cholesterol levels. None of the ratios of
noncholesterol sterols to cholesterol were associated with
serum total cholesterol level.
The ratios of the precursor sterols were inversely related
to those of plant sterols (p , 0.01) and HDL cholesterol,
and positively to serum triglyceride concentration and body
mass index (Table 3). The two latter variables were inversely
associated with the plant sterols and cholestanol ratios. The
GHbA1c% was positively associated with the concentra-
tions of LDL cholesterol and serum triglycerides, and
inversely with HDL cholesterol and serum SHBG levels,
whereas blood glucose and insulin values were inversely
correlated with the plant sterol ratios. Family history of
CAD was correlated with the ratios of squalene (p , 0.001),
desmosterol (p 5 0.030) and sitosterol (p 5 0.040). The
correlations cited here were not different between the
women with and without hormone replacement therapy.
Association between CAD and risk factors. In univariate
analysis, the presence of CAD was positively associated with
family history of CAD, hypertension, smoking, LDL cho-
lesterol level, GHbA1c% and the ratios of squalene, desmo-
sterol, campesterol and sitosterol and inversely with HDL
cholesterol level and lathosterol ratio (Table 4). Adjustment
for age, body mass index, family history of CAD, smoking,
hypertension, LDL and HDL cholesterol levels, serum
triglycerides and GHbA1c% eliminated the association of
CAD with desmosterol, attenuated the association with
lathosterol and did not affect the associations with squalene
and plant sterols. In addition to the sterols, only GHbA1c%
was significantly associated with CAD in all models. The
presence of CAD was associated with LDL only in the
squalene model (Model 1, Table 4), with smoking in the
lathosterol model (Model 3, Table 4) and with family
history of CAD in all except the squalene model. Adding
SHBG, insulin and blood glucose to the models separately
and substituting LDL cholesterol with serum total choles-
terol in each model did not materially alter the results.
The presence of CAD was predicted by the squalene to
cholesterol ratio stronger than was LDL cholesterol and
serum triglycerides (Fig. 2). Thus, the area under ROC
curves for the squalene ratio, LDL cholesterol and serum
triglycerides were 0.885, 0.651 and 0.617, respectively,
Table 2. Fasting Serum Squalene and Noncholesterol Sterols
Variable
Concentration, mg/dl
Ratio, 102 3 mmol/mol of
Cholesterol
Cases
(n 5 48)
Controls
(n 5 61)
Cases
(n 5 48)
Controls
(n 5 61)
Squalene 91.3 6 2.4‡ 60.8 6 2.1 42.1 6 1.2‡ 28.2 6 0.9
D8-Cholestenol 33.2 6 1.9 34.5 6 2.1 15.1 6 0.1 15.9 6 0.9
Desmosterol 212.4 6 17.9* 163.3 6 4.8 97.6 6 8.8† 75.6 6 2.0
Lathosterol 373.8 6 20.0* 425.5 6 16.5 170.6 6 8.2* 196.2 6 6.7
Cholestanol 284.6 6 13.8 282.4 6 10.8 129.8 6 5.7 129.5 6 3.8
Campesterol 610.9 6 44.3* 493.4 6 24.8 278.3 6 18.6* 227.9 6 10.9
Sitosterol 332.3 6 21.7* 271.0 6 13.2 151.5 6 9.1* 124.9 6 5.6
Mean 6 SE. *p , 0.05; †p , 0.01; ‡p , 0.001, cases vs. controls.
Table 3. Correlations Between Factors Related to CAD
Variable
Serum
Squalene
Serum D8-
Cholestenol
Serum
Desmosterol
Serum
Lathosterol
Serum
Campesterol
Serum
Sitosterol
Serum
Cholestanol
Blood
GHbA1c
Body mass index 20.05 0.40‡ 0.42‡ 0.47‡ 20.22* 20.27† 20.39‡ 0.11
Serum squalene 1.00 20.03 0.21* 20.10 0.19* 0.20* 0.16 0.28†
Serum cholesterol 20.17 20.01 20.14 20.05 20.07 20.05 20.01 0.12
LDL cholesterol 20.05 20.05 20.13 20.13 0.08 0.12 0.11 0.20*
HDL cholesterol 20.27† 20.27† 20.35‡ 20.19* 0.00 20.06 0.07 20.25†
Serum triglycerides 0.17 0.47‡ 0.44‡ 0.35‡ 20.33‡ 20.30† 20.39‡ 0.25†
Blood GHbA1c 0.28† 0.05 0.22* 0.00 20.01 0.01 20.09 1.00
Blood glucose 20.09 0.08 0.15 0.17 20.34‡ 20.40‡ 20.30† 0.17
Serum insulin 0.05 0.28† 0.30† 0.35‡ 20.24* 20.23* 20.28† 0.21*
Serum SHBG 0.11 20.27† 20.24* 20.32‡ 0.09 0.05 0.14 20.28†
Values are Spearman’s rank correlation coefficients (n 5 109).
GHbA1c 5 glycosylated hemoglobin A1c; SHBG 5 sex hormone binding globulin.
Squalene and noncholesterol sterol values are in terms of 102 3 mmol/mol of cholesterol.
*p , 0.05; †p , 0.01; ‡p , 0.001.
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indicating that the squalene quartiles correctly predict cases
and controls with a probability of 88.5%, LDL with 65.1%
and serum triglycerides with 61.7%.
DISCUSSION
Cholesterol metabolism reflected by noncholesterol ste-
rols. The present study revealed the independent associa-
tions of serum squalene, lathosterol, campesterol and sitos-
terol with the presence of angiographically documented
CAD in postmenopausal women. High serum squalene may
be a sign for enhanced risk of CAD, and it was related to
serum cholesterol concentration. It has been shown that low
lathosterol and high plant sterol ratios reflect low cholesterol
synthesis rate and high cholesterol absorption efficiency in
normal subjects (11). Thus, independent inverse association
of lathosterol and positive associations of campesterol and
sitosterol with CAD suggest that low synthesis and high
absorption of cholesterol may be related to atherosclerosis in
women independently of other lipid and nonlipid risk
factors. Low cholesterol synthesis in the CAD women could
be a consequence of high cholesterol absorption, but
whether it is associated with low cholesterol elimination has
to be studied further by sterol-balance technique studies.
Even though contraceptive pills increase cholesterol precur-
sor levels in platelets (23), in the present population the
women with exogenous hormone substitution had similar
serum squalene and noncholesterol sterol concentrations as
those without the substitution.
High serum squalene concentrations in CAD women.
Squalene in human atherosclerotic plaques (14) could orig-
inate from de novo synthesis (24) or from the circulation. In
fact, 70% of basal serum squalene is carried in LDL (25), so
that squalene could accumulate in atheroma via LDL
infiltration. Why then is serum squalene concentration
elevated in CAD? It could originate from diet and from
endogenous synthesis. Dietary intake levels of fat and
cholesterol were similar in the two present groups, suggest-
Figure 1. Association between serum squalene to cholesterol ratio
and serum total cholesterol. Closed circles are cases and open
circles are controls.
Ta
bl
e
4.
A
ss
oc
ia
tio
ns
B
et
w
ee
n
R
is
k
Fa
ct
or
s
an
d
C
or
on
ar
y
A
rt
er
y
D
is
ea
se
V
ar
ia
bl
e
U
ni
va
ri
at
e
A
na
ly
si
s
M
ul
ti
va
ri
at
e
A
na
ly
si
s
M
od
el
1
M
od
el
2
M
od
el
3
M
od
el
4
M
od
el
5
A
ge
0.
95
(0
.8
5–
1.
07
)
1.
04
(0
.8
4–
1.
29
)
0.
97
(0
.8
3–
1.
13
)
0.
98
(0
.8
4–
1.
15
)
1.
01
(0
.8
6–
1.
17
)
1.
00
(0
.8
6–
1.
17
)
B
od
y
m
as
s
in
de
x
0.
96
(0
.8
7–
1.
06
)
0.
90
(0
.7
2–
1.
13
)
0.
85
(0
.7
3–
0.
99
)
0.
96
(0
.8
2–
1.
12
)
0.
89
(0
.7
8–
1.
04
)
0.
90
(0
.7
8–
1.
05
)
Fa
m
ily
hi
st
or
y
of
C
A
D
8.
88
(3
.5
7–
22
.1
)‡
3.
87
(0
.7
8–
19
.2
)
6.
98
(2
.2
3–
21
.8
)‡
6.
72
(2
.1
0–
21
.4
)‡
6.
02
(1
.9
3–
18
.7
)‡
6.
08
(1
.9
5–
19
.0
)‡
Sm
ok
in
g
2.
49
(1
.1
1–
5.
60
)*
2.
31
(0
.5
6–
9.
48
)
2.
32
(0
.7
9–
6.
84
)
3.
84
(1
.2
2–
12
.1
)*
2.
71
(0
.9
4–
7.
84
)
2.
89
(0
.9
9–
8.
39
)
H
yp
er
te
ns
io
n
2.
37
(1
.0
3–
5.
42
)*
2.
32
(0
.4
8–
11
.1
)
1.
51
(0
.5
1–
4.
47
)
2.
02
(0
.6
4–
6.
42
)
1.
91
(0
.6
2–
5.
88
)
2.
02
(0
.6
4–
6.
39
)
L
D
L
ch
ol
es
te
ro
l
1.
56
(1
.0
2–
2.
41
)*
3.
94
(1
.2
8–
12
.2
)*
1.
53
(0
.8
5–
2.
77
)
1.
21
(0
.6
6–
2.
23
)
1.
46
(0
.8
0–
2.
65
)
1.
48
(0
.8
1–
2.
71
)
H
D
L
ch
ol
es
te
ro
l
0.
13
(0
.0
3–
0.
52
)†
1.
84
(0
.0
9–
34
.7
)
0.
54
(0
.0
7–
4.
01
)
0.
22
(0
.0
3–
1.
77
)
0.
39
(0
.0
5–
2.
92
)
0.
45
(0
.0
6–
3.
21
)
Se
ru
m
tr
ig
ly
ce
ri
de
s
1.
47
(0
.8
2–
2.
63
)
1.
19
(0
.4
4–
3.
20
)
1.
05
(0
.4
4–
2.
51
)
1.
65
(0
.6
8–
3.
99
)
1.
75
(0
.7
3–
4.
24
)
1.
67
(0
.6
9–
4.
05
)
G
H
bA
1c
3.
41
(2
.2
1–
20
.2
)‡
9.
84
(1
.2
8–
75
.9
)*
5.
59
(1
.4
0–
22
.3
)*
8.
45
(2
.0
0–
35
.8
)†
7.
94
(1
.9
7–
32
.0
)†
8.
42
(2
.0
7–
34
.2
)†
Sq
ua
le
ne
§
1.
30
(1
.1
8–
1.
43
)‡
1.
36
(1
.1
7–
1.
57
)‡
—
—
—
—
D
es
m
os
te
ro
l§
1.
02
(1
.0
0–
1.
05
)†
—
1.
03
(0
.9
9–
1.
06
)
—
—
—
L
at
ho
st
er
ol
§
0.
99
(0
.9
8–
0.
99
)*
—
—
0.
98
(0
.9
7–
0.
99
)†
—
—
C
am
pe
st
er
ol
§
1.
00
(1
.0
0–
1.
01
)*
—
—
—
1.
01
(1
.0
0–
1.
01
)*
—
Si
to
st
er
ol
§
1.
01
(1
.0
0–
1.
02
)*
—
—
—
—
1.
01
(1
.0
0–
1.
03
)*
V
al
ue
s
ar
e
od
ds
ra
tio
(9
5%
C
I)
.
C
A
D
5
co
ro
na
ry
ar
te
ry
di
se
as
e;
G
H
bA
1c
5
gl
yc
os
yl
at
ed
he
m
og
lo
bi
n
A
1c
.
*p
,
0.
05
;†
p
,
0.
01
;‡
p
,
0.
00
1.
§V
ar
ia
bl
es
ar
e
in
te
rm
s
of
10
2
3
m
m
ol
/m
ol
of
ch
ol
es
te
ro
l.
1189JACC Vol. 35, No. 5, 2000 Rajaratnam et al.
April 2000:1185–91 Squalene and Sterols in Coronary Women
ing also that squalene intake was similar. Furthermore, the
dietary diaries indicated that dietary squalene sources (e.g.,
olive oil) were poorly consumed by the present women.
Considering minimal dietary intake of squalene, less than
0.5 g/day, which is known to have no effect on its serum
level (26), differences in intestinal squalene absorption could
hardly explain the differences of serum squalene in the two
groups. Thus, the high squalene levels in the coronary
patients were most likely of endogenous origin.
Cholesterol synthesis decreases with increasing serum
cholesterol level (8,27). The inverse association of squalene
to cholesterol ratio with serum cholesterol in the coronary
patients suggests that the higher the serum cholesterol level
the lower the squalene synthesis. This type of association
was less consistent in the control women. Serum squalene
concentrations most likely reflect endogenous presqualene
cholesterol synthesis, but its association with overall choles-
terol synthesis is controversial, especially in chronic situa-
tions (9). We sense that in acute metabolic changes, as in
diurnal variation (25) and after apheresis (28), serum
squalene ratios increase with increasing cholesterol synthe-
sis. Squalene was not correlated either with body mass index
or with the precursor sterols except with desmosterol,
indicating cholesterol synthesis through the unsaturated
side-chain pathway rather than the saturated one. Further-
more, low lathosterol ratios in the coronary women may also
imply that high squalene ratio is not due to high cholesterol
synthesis rate, but reflects difficulties in further conversion
of squalene to cholesterol, some being metabolized through
desmosterol.
Plant sterols. Coronary patients with high baseline cho-
lestanol and plant sterol ratios to cholesterol appear to be
clinically resistant to lowering of coronary recurrence by
simvastatin, a finding partly contributed by further increase
of plant sterol ratios during statin treatment (13). High
serum plant sterols themselves are strongly atherogenic,
especially in phytosterolemia (29,30). In fact, the plant
sterol ratios were increased in the present cases, suggesting
that absorption of cholesterol and plant sterols was in-
creased because dietary plant sterol intakes were similar in
the two groups. It remains to be shown what the lowest
plant sterol levels are that contribute to enhanced CAD risk.
Glycosylated hemoglobin A1c%. Glycosylated hemoglo-
bin A1c% was independently associated with the presence of
CAD in the postmenopausal women, in agreement with a
previous study (31). Its positive association with LDL
cholesterol and serum triglycerides and negative association
with HDL cholesterol level might partly explain its relation
to CAD. In addition, its association with squalene and
desmosterol indicates that high cholesterol synthesis
through unsaturated side-chain pathway characterizes
women with high normal blood GHbA1c%.
Study limitations and future plans. The control women
had no clinical manifestation of CAD, and the rest ECG
was normal, such that stress ECG was not considered to be
necessary. In fact, this was a case-control study, in which the
controls had significantly different CAD risk factors from
the CAD patients with narrow selection criteria. Prospec-
tive studies of the healthy women and CAD patients on
hypolipidemic treatments will show stability and possible
drug-induced changes of the findings.
Conclusions. The prevalence of CAD in postmenopausal
women was independently and positively associated with
the ratios of squalene, campesterol and sitosterol to choles-
terol and inversely with the respective lathosterol value,
suggesting that high absorption and low synthesis of cho-
lesterol might play a significant role in the development of
atherosclerosis. Thus, altered cholesterol metabolism in
postmenopausal women without or with CAD cannot be
evaluated only from serum cholesterol level; rather, it needs
quantification of basal serum squalene and noncholesterol
sterols, which also would reveal information about the risk
for CAD, especially in combination with family history of
CAD and GHbA1c%. Serum cholesterol lowering is par-
tially influenced by the pattern of cholesterol metabolism,
indicating that combined malabsorption with inhibition of
synthesis of cholesterol by stanol ester margarine and
statins, respectively, would be an effective hypolipidemic
measure for postmenopausal coronary patients (13,32).
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